
393: A conversation with the 'godfather' of biotech
The Readout Loud
00:00
Lilly's ratatrutide diabetes and weight results
Elaine explains Lilly's triple‑agonist trial: notable HbA1c drops and up to 15% weight loss, with questions about subgroup data.
Play episode from 04:38
Transcript


